Fenofibric acid plus statin combination therapy for the treatment of mixed dyslipidemia
Author:
Affiliation:
1. Section of Atherosclerosis & Vascular Medicine, Baylor College of Medicine, 6565 Fannin St #A601, Houston, TX 77030, USA, Tel.: , Fax.:,
Publisher
Informa UK Limited
Subject
Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism
Link
https://www.tandfonline.com/doi/pdf/10.2217/clp.09.71
Reference70 articles.
1. Zhu T, Awni WM, Hosmane B et al.: ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans. J. Clin. Pharmacol. 49(1), 63–71 (2009).
2. Franssen R, Vergeer M, Stroes ES, Kastelein JJ: Combination statin-fibrate therapy: safety aspects. Diabetes Obes. Metab. 11(2), 89–94 (2009).
3. Jacobson TA: Myopathy with statin-fibrate combination therapy: clinical considerations. Nat. Rev. Endocrinol. 5(9), 507–518 (2009).
4. Jones PH: Fibrates. In: Clinical Lipidology: A Companion to Braunwald’s Heart Disease 1st Edition. Ballantyne CM (Ed.). Saunders Elsevier, PA, USA 315–328 (2009).
5. Seth Loomba R, Arora R: Fibrates: where are we now? Ther. Adv. Cardiovasc. Dis. 3(1), 91–96 (2009).
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination Rosuvastatin Plus Fenofibric Acid in a Cohort of Patients 65 Years or Older With Mixed Dyslipidemia: Subanalysis of Two Randomized, Controlled Studies;Clinical Cardiology;2010-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3